Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Recent advances in the pathophysiologic understanding of coronavirus disease 2019 (COVID-19) suggests that cytokine release syndrome (CRS) has an association with the severity of disease, which is characterized by increased tumor necrosis factor α (TNF-α), interleukin (IL)-6, IL-2, IL-7, and IL-10....
Saved in:
Main Authors: | Yi Guo (Author), Ke Hu (Author), Yuxuan Li (Author), Chanjun Lu (Author), Ken Ling (Author), Chuanqi Cai (Author), Weici Wang (Author), Dawei Ye (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and Validation of PTGS2 Gene as an Oxidative Stress-Related Biomarker for Arteriovenous Fistula Failure
by: Ke Hu, et al.
Published: (2023) -
Controversies and Recent Advances in Senescence and Aging
Published: (2023) -
Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease
by: Jay Gupta, et al.
Published: (2023) -
Platinum Accumulation and Cancer-Related Fatigue, Correlation With IL-8, TNF-α and Hemocytes
by: Yuling Zhang, et al.
Published: (2021) -
In silico prediction of phytoconstituents from Ehretia laevis targeting TNF-α in arthritis
by: Subhash R. Yende, et al.
Published: (2021)